Table 1.
Study (author and year) | Country | Design | Setting | NOS | Follow-up | Primary end point |
---|---|---|---|---|---|---|
Zhou et al. (2020) [17] | China | Observational | Single center | 4 (2,0,2) | In hospital | Death |
Zhang et al. (2020) [18] | China | Observational | Single center | 4 (2,0,2) | In hospital | Death |
Takeda et al. (2020) [19] | Japan | Observational | Multicenter | 4 (2,0,2) | In hospital | Death |
Jacobs et al. (2020) [20] | USA | Observational | Multicenter | 4 (2,0,2) | In hospital | Death |
Yang et al. (2020) [21] | China | Observational | Single center | 6 (2,2,2) | In hospital | Death |
Ruan et al. (2020) [22] | China | Observational | Single center | 6 (2,2,2) | In hospital | Death |
Li et al. (2020) [23] | China | Observational | Single center | 6 (2,2,2) | In hospital | Death |
Guan et al. (2020) [24] | China | Observational | Single center | 6 (2,2,2) | In hospital | Death |
Zeng et al. (2020) [25] | China | Observational | Single center | 4 (2,0,2) | In hospital | Death |
Beyls et al. (2020) [26] | France | Observational | Single center | 5 (3,0,2) | 4 weeks after discharge | Death |
Osho et al. (2020) [27] | USA | Observational | Single center | 4 (2,0,2) | In hospital | Death |
Haye et al. (2020) [28] | France | Observational | Single center | 4 (2,0,2) | In hospital | Death |
NOS Newcastle-Ottawa scale (total score with 3 numbers of subdivision: selection of study groups, comparability of groups, and ascertainment of exposure)